Literature DB >> 10364628

Serum and urine selenium concentrations in patients with cardiovascular diseases and relationship to other nutritional indexes.

M Navarro-Alarcón1, H López-Garcia de la Serrana, V Pérez-Valero, C López-Martínez.   

Abstract

Serum and urine selenium levels were determined in patients with cardiovascular diseases by hydride generation atomic absorption spectrometry. Mean serum Se concentrations measured in patients with acute myocardial infarction (AMI; n = 32) or with ischemic cardiomyopathy (n = 50) were significantly lower than those determined in control groups. In AMI patients, serum triglyceride levels showed a positive significant correlation with the serum Se concentration (r = 0.59, p < 0.05). This result reinforces the important role of Se as an antioxidant agent in this disease. Mean urine Se concentrations of AMI patients (n = 33) were also significantly lower to those determined in the control group (p < 0. 05). This reaction of the organism contributes to regulate the Se homeostasis to keep the body Se status as high as possible.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364628     DOI: 10.1159/000012764

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  8 in total

1.  Alterations in serum selenium levels and their relation to troponin I in acute myocardial infarction.

Authors:  Barbara Kutil; Petr Ostadal; Jiri Vejvoda; Jiri Kukacka; Jana Cepova; David Alan; Andreas Krüger; Dagmar Vondrakova
Journal:  Mol Cell Biochem       Date:  2010-08-01       Impact factor: 3.396

2.  Selenium and coronary heart disease: a meta-analysis.

Authors:  Gemma Flores-Mateo; Ana Navas-Acien; Roberto Pastor-Barriuso; Eliseo Guallar
Journal:  Am J Clin Nutr       Date:  2006-10       Impact factor: 7.045

Review 3.  Micronutrients in chronic heart failure.

Authors:  Selim R Krim; Patrick Campbell; Carl J Lavie; Hector Ventura
Journal:  Curr Heart Fail Rep       Date:  2013-03

4.  Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study.

Authors:  Renate Schnabel; Edith Lubos; Claudia M Messow; Christoph R Sinning; Tanja Zeller; Philipp S Wild; Dirk Peetz; Diane E Handy; Thomas Munzel; Joseph Loscalzo; Karl J Lackner; Stefan Blankenberg
Journal:  Am Heart J       Date:  2008-12       Impact factor: 4.749

5.  Intake of partially defatted Brazil nut flour reduces serum cholesterol in hypercholesterolemic patients--a randomized controlled trial.

Authors:  Roberta F Carvalho; Grazielle V B Huguenin; Ronir R Luiz; Annie S B Moreira; Glaucia M M Oliveira; Glorimar Rosa
Journal:  Nutr J       Date:  2015-06-16       Impact factor: 3.271

6.  Assessing the Efficacy of Dietary Selenomethionine Supplementation in the Setting of Cardiac Ischemia/Reperfusion Injury.

Authors:  Leila Reyes; David P Bishop; Clare L Hawkins; Benjamin S Rayner
Journal:  Antioxidants (Basel)       Date:  2019-11-13

7.  The Gut Microbiome, Seleno-Compounds, and Acute Myocardial Infarction.

Authors:  Fu-Chun Chiu; Chin-Feng Tsai; Pang-Shuo Huang; Ching-Yu Shih; Mong-Hsun Tsai; Juey-Jen Hwang; Yi-Chih Wang; Eric Y Chuang; Chia-Ti Tsai; Sheng-Nan Chang
Journal:  J Clin Med       Date:  2022-03-07       Impact factor: 4.241

8.  The Relationship Between Plasma Selenium, Antioxidant Status, Inflammatory Responses and Ischemic Cardiomyopathy: A Case-Control Study Based on Matched Propensity Scores.

Authors:  Yinhua Luo; Xiaohong He; Linbo Hu; Jinbo Zhao; Ke Su; Yuhua Lei; Yuanhong Li
Journal:  J Inflamm Res       Date:  2022-10-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.